[The New York Times] $300,000 Drug

There is one other way that Kalydeco is an excellent example of personalized medicine: its cost. It’s more than $300,000 a year. Because patients will likely be taking the drug for the rest of their lives, it could cost millions of dollars to keep just one patient on Kalydeco. That raises another important question about the coming of personalized medicine.

How are we, as a society, going to pay for it?

First Name*
Last Name*
Email*
CAPTCHA
FP1 Tracking: Basic Data
Origin URL Page Title Source URL Query String Date Time
FP1 Tracking: UTM Data
UTM Source UTM Medium UTM Campaign
FP1 Iterable: Lists
Lists
FP1 Iterable: Workflows
Workflows
Comments
This field is for validation purposes and should be left unchanged.

News & Updates

[The New York Times] $300,000 Drug

Sign-up for updates